摘要
近几十年来,食管胃结合部腺癌的发病率正在逐年上升。Her-2表达与食管胃结合部腺癌预后的研究结果呈现争议,研究认为这是因为Her-2检测的局限性和组织标本的异质性而导致不同的结果。对于Her-2过表达的食管胃结合部腺癌,综合治疗包括新辅助放化疗、辅助放化疗、手术治疗及靶向治疗在临床疗效中的地位越来越突出,中医药治疗也在辅助治疗中起到重要作用。
In recent decades, the incidence of gastroesophageal jmwtion （ GEJ ）adenocarcinomas is incl^asing. The relationship between Her-2 expression and prognosis of GEJ adenocareinomas shows controvemy. It leads to different results because of Her-2 detection limitations and tissue heterogeneity. For GEJ adenocarcinomas with Her-2 overexpression,comprehensive therapy in- cluding neoadjuvant chemotherapy,adjuvan! radiotherapy,surgery and targeted therapy is becom- ing more and more prominent in the clinic. Traditional Chinese medicine has played an important role in the adjuvant therapy.
出处
《中国肿瘤》
CAS
2015年第1期49-52,共4页
China Cancer
基金
浙江省自然科学基金(LY13H290013)
浙江省中医药科技计划项目(2013ZA043)
关键词
食管胃结合部腺癌
人类表皮生长因子受体2
综合治疗
gastroesophageal junction adenocarcinomas
human epidermal growth factor receptor 2
comprehensive therapy
